Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05676541Not ApplicableCompleted

Enhanced Care for Patients With Complex Multimorbidity in Primary Care

Role: collaborator

NCT02716168Not ApplicableCompleted

Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy

Role: collaborator

NCT02612467Not ApplicableCompleted

Low Back Pain - What's Next? Stratified Care Compared to Current Practice

Role: collaborator

NCT02595515Not ApplicableCompleted

The Effect of Chiropractic Treatment of Infantile Colic

Role: collaborator

NCT01853865Not ApplicableUnknown

Follow-up of Endometrial Cancer Patients

Role: collaborator

NCT00120315Phase 4Completed

Proton Pump Inhibitor Treatment Stop

Role: collaborator

All 6 trials loaded